statistiche ricercatore

BRUNO, ANTONINO

Distribuzione geografica

Continente	#
NA - Nord America	9.093
EU - Europa	5.441
AS - Asia	3.846
SA - Sud America	492
AF - Africa	87
OC - Oceania	20
Continente sconosciuto - Info sul continente non disponibili	15
Totale	18.994

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	8.908
IT - Italia	2.847
SG - Singapore	1.382
CN - Cina	841
VN - Vietnam	484
HK - Hong Kong	471
UA - Ucraina	434
DE - Germania	401
BR - Brasile	400
SE - Svezia	350
GB - Regno Unito	255
TR - Turchia	252
FR - Francia	249
IE - Irlanda	219
FI - Finlandia	196
RU - Federazione Russa	153
CA - Canada	101
IN - India	101
JP - Giappone	78
MX - Messico	69
NL - Olanda	62
BD - Bangladesh	54
PL - Polonia	48
ES - Italia	46
AR - Argentina	36
ZA - Sudafrica	34
AT - Austria	32
CZ - Repubblica Ceca	29
BE - Belgio	28
IQ - Iraq	25
ID - Indonesia	20
CH - Svizzera	19
LT - Lituania	18
NG - Nigeria	16
AU - Australia	15
MY - Malesia	15
PK - Pakistan	15
EC - Ecuador	13
TH - Thailandia	12
EU - Europa	11
SA - Arabia Saudita	11
CO - Colombia	10
IR - Iran	10
KR - Corea	10
VE - Venezuela	10
CL - Cile	9
PH - Filippine	9
TN - Tunisia	8
UZ - Uzbekistan	8
AE - Emirati Arabi Uniti	7
MA - Marocco	7
PY - Paraguay	7
GR - Grecia	6
IL - Israele	6
KE - Kenya	6
MD - Moldavia	6
RO - Romania	6
DK - Danimarca	5
DZ - Algeria	5
EG - Egitto	5
NZ - Nuova Zelanda	5
TW - Taiwan	5
AZ - Azerbaigian	4
HU - Ungheria	4
NO - Norvegia	4
PE - Perù	4
SK - Slovacchia (Repubblica Slovacca)	4
A2 - ???statistics.table.value.countryCode.A2???	3
AL - Albania	3
BG - Bulgaria	3
IS - Islanda	3
JO - Giordania	3
KZ - Kazakistan	3
NP - Nepal	3
OM - Oman	3
BF - Burkina Faso	2
CR - Costa Rica	2
EE - Estonia	2
HN - Honduras	2
KG - Kirghizistan	2
LB - Libano	2
LK - Sri Lanka	2
LU - Lussemburgo	2
LV - Lettonia	2
MC - Monaco	2
RS - Serbia	2
SN - Senegal	2
BH - Bahrain	1
BN - Brunei Darussalam	1
BO - Bolivia	1
BS - Bahamas	1
BY - Bielorussia	1
CG - Congo	1
CY - Cipro	1
DM - Dominica	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GD - Grenada	1
GE - Georgia	1
GL - Groenlandia	1
Totale	18.981

Salva come PNG Salva come JPEG

Città	#
Milan	1.618
San Jose	854
Ashburn	842
Singapore	841
Fairfield	646
Chandler	559
Woodbridge	546
Hong Kong	460
Houston	429
Jacksonville	357
Dallas	327
Ann Arbor	315
Seattle	266
Beijing	259
Wilmington	235
Como	233
Cambridge	223
Dublin	215
The Dalles	208
Los Angeles	205
Boardman	181
Nyköping	179
Princeton	175
Chicago	160
New York	145
Rome	126
Dearborn	124
Lauterbourg	121
Council Bluffs	120
Izmir	110
Ho Chi Minh City	99
Dong Ket	91
Munich	85
Hanoi	84
London	82
Helsinki	72
Varese	63
Santa Clara	62
São Paulo	62
Buffalo	58
Tokyo	55
San Diego	53
Turku	45
Orem	44
Mexico City	42
Warsaw	41
Washington	40
Frankfurt am Main	39
Salt Lake City	38
Montreal	37
Des Moines	35
Stockholm	35
Denver	34
Brooklyn	31
Nuremberg	31
Guangzhou	29
Ogden	29
Manchester	28
Brussels	27
Johannesburg	27
Shanghai	27
Gallarate	26
Brno	25
Chennai	25
Elk Grove Village	25
Poplar	24
Amsterdam	23
San Francisco	23
Toronto	23
Atlanta	22
Phoenix	21
Vienna	20
Düsseldorf	19
Kocaeli	19
Boston	18
Magnago	16
Tampa	16
Hefei	14
Abuja	13
Cantù	13
Genoa	13
Verona	13
Da Nang	12
Kunming	12
Tianjin	12
Basingstoke	11
Berlin	11
Cavaria con Premezzo	11
Jinan	11
Monza	11
Moscow	11
Norwalk	11
Pune	11
San Mateo	11
Ankara	10
Chengdu	10
Gorgonzola	10
Pittsburgh	10
Querétaro	10
Rio de Janeiro	10
Totale	13.210

Salva come PNG Salva come JPEG

Nome	#
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	302
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	300
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	282
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: Systemic distribution, macrophage accumulation, and amyloid deposition	264
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?	252
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity	247
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis	244
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	238
Proline Dehydrogenase affects lung cancer cell proliferation by inducing ROS and cellular senescence	237
Biomarkers of cancer angioprevention for clinical studies	235
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection	233
Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells	231
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	231
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	224
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects	221
Effect of a Purified Extract of Olive Mill Waste Water on Endothelial Cell Proliferation, Apoptosis, Migration and Capillary-Like Structure in vitro and in vivo.	219
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues	216
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	215
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo	215
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes	209
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	208
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	207
SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses	207
Orchestration of angiogenesis by immune cells	200
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention	199
Unravelling the role of proline dehydrogenase (PRODH) in lung adenocarcinoma: implications for cellular senescence and the tumor microenvironment	198
Fenretinide (4-HPR) targets caspase-9, ERK 1/2 and the Wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids	192
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy	192
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	192
SANIST: A rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers	191
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	190
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	187
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	186
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	186
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	183
Paradoxic effects of metformin on endothelial cells and angiogenesis.	182
The Angiogenic Switch: Role of Immune Cells	172
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic eﬀectors	168
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature	166
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	165
Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation	163
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	163
Proline Dehydrogenase as a player in acquired resistance to Tyrosine Kinase Inhibitors	162
Mutant alleles in Aicardi-Goutieres syndrome patients produce a disfunctional RNASET2 protein associated with alterations in interferon signalling.	161
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	161
MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2	159
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state.	159
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors.	158
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset	156
Downregulation of pro-inflammatory and pro-angiogenic pathways in prostate cancer cells by a polyphenol-rich extract from olive mill wastewater	151
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment	149
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients	149
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC)	148
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells	147
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis	146
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	144
Nutraceuticals and “repurposed” drugs of phytochemical origin in prevention and interception of chronic degenerative diseases and cancer	143
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients	140
Microalgal derivatives as potential nutraceutical and food supplements for human health: A focus on cancer prevention and interception	139
Functional and phenotypic characterization of tumor infiltrating NK cells.	137
The Pharmacologist’s Point of View: Mechanisms of Cardiotoxicity	136
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors	135
The NK cells phenotype and function in resected non small cell lung cancer: differences between squamous and adenocarcinoma.	134
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher	133
VEGFR2 and CXCR4 pathways are modulated by acetyl-l-Carnitine that acts as an anti-angiogenic agent	132
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis	132
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	131
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non small cell lung cancer (NSCLC)	130
Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer	130
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors	129
Functional and phenotypic characterization of tumor infiltrating NK cells to identify novel targets for anticancer therapy.	129
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis	128
Natural killer cells from malignant pleural effusion are switched toward an NK proangiogenic polarization	128
Prostate cancer associated natural killer cells show a pro-angiogenic and pro-inflammatory phenotype.	128
A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity	128
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3	127
The role of natural killer cells in lung cancer angiogenesis	126
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells	126
NK cells-modulation of tumor angiogenesis.	125
The role of tumor infiltrating and tumor associated natural killer cells in promotion of angiogenesis in colorectal cancer patients	125
Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis	124
Human Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support theGeneratio of a Vascular Network In Vivo	124
Serum steroid ratio profiles in prostate cancer: A new diagnostic tool toward a personalized medicine approach	123
NK cells as modulators of tumor angiogenesis	122
Proline Dehydrogenase (PRODH) Is Expressed in Lung Adenocarcinoma and Modulates Cell Survival and 3D Growth by Inducing Cellular Senescence	121
The cell-autonomous and non-cell autonomous activities of the alarmin-like RNASET2 protein in prostate cancer models	121
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity	120
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity	120
A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification	118
Natural compounds of marine origin as inducers of immunogenic cell death (ICD): potential role for cancer interception and therapy	115
Subcapsular sinus macrophages promote melanoma metastasis to the sentinel lymph nodes via an IL-1α-STAT3 axis	114
Use of extract of vegetation waters in the regeneration of epithelial tissue	113
TIMP1 and TIMP2 downregulate TGFβ induced decidual-like phenotype in natural killer cells	110
The Dual Role of Natural Killer Cells During Tumor Progression and Angiogenesis: Implications for Tumor Microenvironment-targeted Immunotherapies.	107
Effects of Amorphous Calcium Phosphate Administration on Dental Sensitivity during In-Office and At-Home Interventions	98
Natural Killer Cells in Graves’ Disease: Increased Frequency but Impaired Degranulation Ability Compared to Healthy Controls	96
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory	95
Proline Dehydrogenase as new marker and target in EGFR mutant Non-Small Cell Lung carcinoma	94
The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	94
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA	92
Totale	16.434

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	76.540
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	76.540

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	282	0	0	0	0	0	0	0	0	0	0	133	149
2021/2022	1.015	148	50	21	27	56	51	60	61	174	173	63	131
2022/2023	1.624	143	105	114	208	116	324	7	204	189	75	76	63
2023/2024	2.837	382	390	379	511	580	198	23	60	55	115	14	130
2024/2025	2.832	47	32	345	146	216	146	135	147	315	412	314	577
2025/2026	6.384	466	385	427	951	777	332	1.224	453	639	529	201	0
Totale													19.331